This is due to the action of leptin that counteracts multiple harmful events observed in the pathogenesis of Alzheimer's disease, from aberrations in hippocampal synaptic function to changes in the expression of proteins related to the disease and prevention of neuronal death. Here, LEP is linked to early-onset autosomal dominant Alzheimer disease.